Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
AR ›
ARVACORAM
Trademark search for:
ARVACORAM
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-05-11 — Application filed
2011-12-02 — Sn assigned for sect 66a subseq desig from ib
2011-12-05 — Application filed
2011-12-06 — Change of name/address rec'd from ib
2011-12-06 — Application filed
2011-12-06 — Assigned to examiner
2011-12-10 — Application filed
2011-12-12 — Final disposition recorded
2011-12-13 — Office action issued
2011-12-14 — Office action issued
2011-12-14 — Office action issued
2011-12-30 — Office action issued
2012-06-12 — Attorney/dom.rep.revoked and/or appointed
2012-06-12 — Office action issued
2012-06-12 — Teas revoke/app/change addr of atty/dom rep received
2012-06-22 — Assigned to lie
2012-06-29 — Teas/email correspondence entered
2012-06-29 — Correspondence received in law office
2012-07-10 — Approved for pub - principal register
2012-07-14 — Law office publication review completed
2012-08-01 — Notification of possible opposition sent to ib
2012-08-01 — Notification of notice of publication e-mailed
2012-08-01 — Notice of start of opposition period created, to be sent to ib
2012-08-21 — Published for opposition
2012-08-21 — Official gazette publication confirmation e-mailed
2012-09-29 — Notification processed by ib
2012-11-06 — Registered-principal register
2013-02-06 — Final disposition recorded
2013-02-08 — Final disposition recorded
2013-02-08 — Final disposition recorded
2013-03-03 — Final disposition recorded
2016-09-08 — International registration renewed
2017-11-06 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2019-06-07 — Cancelled section 71
2019-06-07 — Final status recorded
2020-02-07 — Total invalidation of reg ext protection created
2020-05-12 — Total invalidation of reg ext protection sent to ib
2020-05-12 — Invalidation processed
2020-06-05 — Total invalidation processed by the ib
Owner Information
BIOFARMA
F-92284 SURESNES CEDEX FR
BIOFARMA
F-92284 SURESNES CEDEX FR
BIOFARMA
F-92284 SURESNES CEDEX FR
Correspondent
REBECCA B. LEDERHOUSE BAKER & MCKENZIE LLP 300 E. RANDOLPH SUITE 5000 CHICAGO, IL 60601 UNITED STATES
Filing Details
Filing Date:
2011-05-11
Status Date:
2019-06-07
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.